Clinical Trial Update: Aztreonam for Inhalation Solution vs Tobramycin Inhalation Solution in Patients With Cystic Fibrosis & Pseudomonas Aeruginosa [Phase 3]

View source ↗

Summary

Phase 3 trial comparing aztreonam for inhalation solution with tobramycin inhalation solution in cystic fibrosis patients with Pseudomonas aeruginosa. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Aztreonam for inhalation solution (aztreonam for inhalation solution)
• Tobramycin Inhalation Solution (tobramycin inhalation solution)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis | Phase 3 | Status: COMPLETED | Results posted: 2011-07-04